Recently, the CPGR joined The Biomarkers Consortium.
The ‘Biomarkers Consortium’, or ‘Consortium’, is a public-private scientific partnership between the Foundation for the National Institutes of Health (FNIH), the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Centres for Medicare & Medicaid Services (CMS), members of the pharmaceutical, biotechnology, diagnostics, and medical device industries, members of non-profit organizations, and academicians.
Opportunity for creating a ‘Biomarker Development Compact’ in South Africa
Against the backdrop of our involvement with the Consortium, we are exploring the opportunity for creating a local ‘Biomarker Development Compact’, by way of bringing together a group of individuals and organisations who have a strong interest in biomarker development. Our intention is also to attract interest from funders/financiers of such projects (public or private). Ideally, we want to assemble a diversity of stakeholders, from basic science to business, enabling us to tackle the challenges and opportunities in biomarker development effectively.